The “real life” efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP

The “real life” efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP

Abstract Background Dupilumab significantly improves symptom control in chronic rhinosinusitis with nasal polyps (CRSwNP). Patients with large polyps at the initiation of treatment (total polyp score (TPS) ≥ 5) have been the focus in published studies. Patients with significant burden of disease but...

Full description

Bibliographic Details
Main Authors: Nicholas J. Campion, Jonas Brugger, Aldine Tu, Victoria Stanek, Faris F. Brkic, Tina J. Bartosik, David T. Liu, Bruna S. Hoehl, Katharina Gangl, Julia Eckl-Dorna, Sven Schneider
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Journal of Otolaryngology - Head and Neck Surgery
Subjects:
Chronic rhinosinusitis
CRSwNP
Nasal polyp
Asthma
Biological treatment
Online Access:https://doi.org/10.1186/s40463-023-00663-4

Internet

https://doi.org/10.1186/s40463-023-00663-4

Similar Items